ERBB2 and gastroesophageal junction adenocarcinoma: These distinctive properties position ZW25 as a promising option in the treatment of gastrointestinal cancers, particularly in HER2-positive GEJ adenocarcinomas and HER2-positive biliary tract cancers (BTC).